201 related articles for article (PubMed ID: 17907169)
1. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study.
Lim LL; Fraunfelder FW; Rosenbaum JT
Arthritis Rheum; 2007 Oct; 56(10):3248-52. PubMed ID: 17907169
[TBL] [Abstract][Full Text] [Related]
2. Adalimumab in the therapy of uveitis in childhood.
Biester S; Deuter C; Michels H; Haefner R; Kuemmerle-Deschner J; Doycheva D; Zierhut M
Br J Ophthalmol; 2007 Mar; 91(3):319-24. PubMed ID: 17035274
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the inhibition mechanisms of adalimumab and infliximab in treating tumor necrosis factor α-associated diseases from a molecular view.
Hu S; Liang S; Guo H; Zhang D; Li H; Wang X; Yang W; Qian W; Hou S; Wang H; Guo Y; Lou Z
J Biol Chem; 2013 Sep; 288(38):27059-27067. PubMed ID: 23943614
[TBL] [Abstract][Full Text] [Related]
4. Comparative risk of incident and recurrent acute anterior uveitis across different biological agents in patients with ankylosing spondylitis.
Kwon OC; Lee HS; Yang J; Park MC
Rheumatology (Oxford); 2024 Jan; ():. PubMed ID: 38243710
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab in the therapy of uveitis in childhood.
Mansour AM
Br J Ophthalmol; 2007 Mar; 91(3):274-6. PubMed ID: 17322463
[TBL] [Abstract][Full Text] [Related]
6. Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy.
Kreps EO; Epps SJ; Consejo A; Dick AD; Guly CM; Ramanan AV
Eye (Lond); 2024 Apr; 38(5):871-876. PubMed ID: 37848676
[TBL] [Abstract][Full Text] [Related]
7. Role of Tumor Necrosis Factor-α Inhibitors in the Treatment and Occurrence of Acne: A Systematic Review.
Sandoval AGW; Vaughn LT; Huang JT; Barbieri JS
JAMA Dermatol; 2023 May; 159(5):504-509. PubMed ID: 36930143
[TBL] [Abstract][Full Text] [Related]
8. Challenges for further successful development of tumor necrosis factor targeting therapies for uveitis.
Thng ZX; Regenold J; Bromeo AJ; Akhavanrezayat A; Than NTT; Khatri A; Mohammadi SS; Tran ANT; Shin YU; Karaca I; Ghoraba HH; Or CCM; Nguyen QD
Expert Opin Investig Drugs; 2024 Feb; 33(2):95-104. PubMed ID: 38299551
[TBL] [Abstract][Full Text] [Related]
9. Update on the treatment of ankylosing spondylitis.
Maksymowych WP
Ther Clin Risk Manag; 2007 Dec; 3(6):1125-33. PubMed ID: 18516314
[TBL] [Abstract][Full Text] [Related]
10. New onset of uveitis during infliximab treatment: A case report.
Bouladi M; Ben Othmen A; Sawssen M; Kalou M; Laater A; El Fekih L
Tunis Med; 2024 Jan; 102(1):58-60. PubMed ID: 38545732
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry.
Tarsia M; Vitale A; Gaggiano C; Sota J; Maselli A; Bellantonio C; Guerriero S; Dammacco R; La Torre F; Ragab G; Hegazy MT; Fonollosa A; Paroli MP; Del Giudice E; Maggio MC; Cattalini M; Fotis L; Conti G; Mauro A; Civino A; Diomeda F; de-la-Torre A; Cifuentes-González C; Tharwat S; Hernández-Rodríguez J; Gómez-Caverzaschi V; Pelegrín L; Babu K; Gupta V; Minoia F; Ruscitti P; Costi S; Breda L; La Bella S; Conforti A; Mazzei MA; Carreño E; Amin RH; Grosso S; Frediani B; Tosi GM; Balistreri A; Cantarini L; Fabiani C
Ophthalmol Ther; 2024 Mar; 13(3):761-774. PubMed ID: 38206518
[TBL] [Abstract][Full Text] [Related]
12. A review of ocular adverse events of biological anti-TNF drugs.
Nicolela Susanna F; Pavesio C
J Ophthalmic Inflamm Infect; 2020 Apr; 10(1):11. PubMed ID: 32337619
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies for uveitis in spondyloarthritis: A narrative review.
Jacquot R; Kodjikian L; Chapurlat R; Sève P
Joint Bone Spine; 2024 Feb; 91(5):105697. PubMed ID: 38309516
[TBL] [Abstract][Full Text] [Related]
14. Polymer-conjugated inhibitors of tumor necrosis factor-α for local control of inflammation.
Washburn NR; Prata JE; Friedrich EE; Ramadan MH; Elder AN; Sun LT
Biomatter; 2013; 3(3):. PubMed ID: 23903893
[TBL] [Abstract][Full Text] [Related]
15. Predictive Factors for Magnetic Resonance Imaging Changes Suggestive of Demyelination in Adult Patients with Uveitis Scanned Prior to Commencing Adalimumab Therapy.
Sanghi P; Luis J; Ajamil S; Yeung IY; Hindle E; Sandhu S; Hassan S; Turner B; Rees A; Westcott M
Ocul Immunol Inflamm; 2023 Nov; 31(9):1804-1812. PubMed ID: 36099542
[TBL] [Abstract][Full Text] [Related]
16. Update on the use of systemic biologic agents in the treatment of noninfectious uveitis.
Pasadhika S; Rosenbaum JT
Biologics; 2014; 8():67-81. PubMed ID: 24600203
[TBL] [Abstract][Full Text] [Related]
17. Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients.
Calvo-Río V; Blanco R; Santos-Gómez M; Rubio-Romero E; Cordero-Coma M; Gallego-Flores A; Veroz R; Torre I; Hernández FF; Atanes A; Loricera J; González-Vela MC; Palmou N; Hernández JL; González-Gay MA
Semin Arthritis Rheum; 2016 Aug; 46(1):95-101. PubMed ID: 27060872
[TBL] [Abstract][Full Text] [Related]
18. Mimickers of anterior uveitis, scleritis and misdiagnoses- tips and tricks for the cornea specialist.
Caplash S; Paez-Escamilla M; Westcott M; Dansingani KK; Indermill C; Kisma N; Frau E; Sahel JA; Bodaghi B; Jhanji V; Errera MH
J Ophthalmic Inflamm Infect; 2024 Apr; 14(1):14. PubMed ID: 38594487
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Incidence or Recurrence of Anterior Uveitis in Patients with Ankylosing Spondylitis Treated with Tumor Necrosis Factor Inhibitors.
Kwon HY; Kim YJ; Kim TH; Ahn SJ
J Clin Med; 2024 Feb; 13(3):. PubMed ID: 38337605
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
